An Overview of the Indian Pharmaceutical Sector

Mainak Mazumdar ()
Additional contact information
Mainak Mazumdar: Centre De Sciences Humaines (CSH)

Chapter Chapter 2 in Performance of Pharmaceutical Companies in India, 2013, pp 17-44 from Springer

Abstract: Abstract This chapter presents an overview of the Indian Pharmaceutical Industry and traces its evolution and growth. From the review of policies and analysis of the aggregate data, we conclude that the Patent Act of 1970 and the knowledge spill-over from public sector units provided the necessary impetus for the growth of the industry. Presently, the industry is highly competitive with the top 20 firms capturing about 80 % of the market. However, contrary to conventional economic wisdom, evidence also suggests that it is one of the most profitable industries. The coexistence of low concentration and high profit earning is observed due to firm specific factors like its efficiency, returns from R&D and marketing related outlays and earnings from the global market.

Keywords: Sales Volume; Herfindahl Index; Pharmaceutical Sector; Bulk Drug; Capital Intensity (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations: View citations in EconPapers (1)

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:conchp:978-3-7908-2876-4_2

Ordering information: This item can be ordered from
http://www.springer.com/9783790828764

DOI: 10.1007/978-3-7908-2876-4_2

Access Statistics for this chapter

More chapters in Contributions to Economics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().